Business
Friday, September 2, 2016
Breakingviews: Drugmakers' D.C. dealing
As Congress prods Mylan over EpiPen in the latest probe on prescription prices, the pharmaceutical industry's massive lobbying spend gets put to the test. Gina Chon and Jeffrey Goldfarb discuss.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment